Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
—
Presentation highlighted promising results of TRV045 in nonclinical models of neuropathic pain including mechanical and cold-stimulus evoked nociceptive pain in a dose-related manner
Related news for (TRVN)
- Trevena Publicizes TRV045 Preclinical Data
- Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
- Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
- Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings